Your browser doesn't support javascript.
loading
Neurodevelopmental and other phenotypes recurrently associated with heterozygous BAZ2B loss-of-function variants.
Sewani, Soha; Azamian, Mahshid S; Mendelsohn, Bryce A; Mau-Them, Frederic Tran; Réda, Manon; Nambot, Sophie; Isidor, Bertrand; van der Smagt, Jasper J; Shen, Joseph J; Shillington, Amelle; White, Lori; Elloumi, Houda Zghal; Baker, Peter R; Svihovec, Shayna; Brown, Kathleen; Koopman-Keemink, Yvonne; Hoffer, Mariette J V; Lakeman, Inge M M; Brischoux-Boucher, Elise; Kinali, Maria; Zhao, Xiaonan; Lalani, Seema R; Scott, Daryl A.
Afiliación
  • Sewani S; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
  • Azamian MS; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
  • Mendelsohn BA; Texas Children's Hospital, Houston, Texas, USA.
  • Mau-Them FT; Department of Medical Genetics, Kaiser Permanente Oakland Medical Center, Oakland, California, USA.
  • Réda M; UF6254 Innovation en Diagnostic Genomique des Maladies Rares, Dijon, France.
  • Nambot S; Équipe Génétique des Anomalies du Développement (GAD), Dijon, France.
  • Isidor B; Department of Medical Oncology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, France.
  • van der Smagt JJ; Platform of Transfer in Cancer Biology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, France.
  • Shen JJ; Université Bourgogne Franche-Comté, Dijon, France.
  • Shillington A; Genomic and Immunotherapy Medical Institute, Dijon, France.
  • White L; Unité Fonctionnelle Innovation en Diagnostic génomique des maladies rares, FHU-TRANSLAD, Dijon, France.
  • Elloumi HZ; Centre de Référence Maladies Rares "Anomalies du Développement et Syndromes Malformatifs", Centre de Génétique, FHU-TRANSLAD, Dijon, France.
  • Baker PR; Centre Hospitalier Universitaire de Nantes, Service de Génétique Médicale, Nantes, France.
  • Svihovec S; INSERM, CNRS, UNIV Nantes, l'institut du thorax, Nantes, France.
  • Brown K; Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Koopman-Keemink Y; Division of Genomic Medicine, Department of Pediatrics, MIND Institute, University of California, Davis, Sacramento, California, USA.
  • Hoffer MJV; Cincinnati Children's Hospital Medical Center, Department of Human Genetics, Cincinnati, Ohio, USA.
  • Lakeman IMM; Cincinnati Children's Hospital Medical Center Department of Psychiatry, Cincinnati, Ohio, USA.
  • Brischoux-Boucher E; University of Cincinnati College of Medicine Department of Pediatrics, Cincinnati, Ohio, USA.
  • Kinali M; Cincinnati Children's Hospital Medical Center, Department of Human Genetics, Cincinnati, Ohio, USA.
  • Zhao X; Clinical Genomics Program, GeneDx, Gaithersburg, Maryland, USA.
  • Lalani SR; Department of Pediatrics, University of Colorado, Aurora, Colorado, USA.
  • Scott DA; Department of Pediatrics, University of Colorado, Aurora, Colorado, USA.
Am J Med Genet A ; 194(3): e63445, 2024 Mar.
Article en En | MEDLINE | ID: mdl-37872713
ABSTRACT
The bromodomain adjacent to zinc finger 2B (BAZ2B) gene encodes a chromatin remodeling protein that has been shown to perform a variety of regulatory functions. It has been proposed that loss of BAZ2B function is associated with neurodevelopmental phenotypes, and some recurrent structural birth defects and dysmorphic features have been documented among individuals carrying heterozygous loss-of-function BAZ2B variants. However, additional evidence is needed to confirm that these phenotypes are attributable to BAZ2B deficiency. Here, we report 10 unrelated individuals with heterozygous deletions, stop-gain, frameshift, missense, splice junction, indel, and start-loss variants affecting BAZ2B. These included a paternal intragenic deletion and a maternal frameshift variant that were inherited from mildly affected or asymptomatic parents. The analysis of molecular and clinical data from this cohort, and that of individuals previously reported, suggests that BAZ2B haploinsufficiency causes an autosomal dominant neurodevelopmental syndrome that is incompletely penetrant. The phenotypes most commonly seen in association with loss of BAZ2B function include developmental delay, intellectual disability, autism spectrum disorder, speech delay-with some affected individuals being non-verbal-behavioral abnormalities, seizures, vision-related issues, congenital heart defects, poor fetal growth, and an indistinct pattern of dysmorphic features in which epicanthal folds and small ears are particularly common.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Factores Generales de Transcripción / Trastornos del Neurodesarrollo / Trastorno del Espectro Autista / Discapacidad Intelectual Límite: Humans Idioma: En Revista: Am J Med Genet A Asunto de la revista: GENETICA MEDICA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Factores Generales de Transcripción / Trastornos del Neurodesarrollo / Trastorno del Espectro Autista / Discapacidad Intelectual Límite: Humans Idioma: En Revista: Am J Med Genet A Asunto de la revista: GENETICA MEDICA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos